Multicatalytic protease inhibitors for use as anti-tumor agents
CA 2314259 A1 · Owner: University Of Pittsburgh Of The Commonwealth System Of Higher Education · Inventors: Siman, Robert; Dou, Qing Ping; Jani, Jitesh P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to methods for the use of specified inhibitors of multicatalytic protease (MCP) for use as inducers of programmed cell death (i.e. apoptosis) in tumor cells, and more particularly as anti-tumor agents. The present invention provides methods for inducing apoptosis in transformed cells, inhibiting proliferation of transformed cells and inhibiting the , growth of tumors using the MCP inhibitors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 15, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 15, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 15, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.